Consolidated Balance Sheet

Delta-Fly Pharma, Inc. - Filing #7296920

Concept As at
2024-09-30
As at
2024-03-31
Consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
349,122,000 JPY
1,417,062,000 JPY
Other
36,355,000 JPY
15,869,000 JPY
Current assets
385,477,000 JPY
1,432,931,000 JPY
Non-current assets
40,342,000 JPY
41,223,000 JPY
Investments and other assets
2,889,000 JPY
2,980,000 JPY
Non-current assets
Property, plant and equipment
37,452,000 JPY
38,242,000 JPY
Property, plant and equipment
Investments and other assets
Assets
425,820,000 JPY
1,474,155,000 JPY
Liabilities and net assets
Current liabilities
110,311,000 JPY
241,498,000 JPY
Accounts payable - other
83,492,000 JPY
207,070,000 JPY
Liabilities
110,311,000 JPY
241,498,000 JPY
Shareholders' equity
314,758,000 JPY
1,231,906,000 JPY
Share capital
4,731,185,000 JPY
4,731,185,000 JPY
Capital surplus
4,711,185,000 JPY
4,711,185,000 JPY
Retained earnings
-9,127,273,000 JPY
-8,210,125,000 JPY
Treasury shares
-337,000 JPY
-337,000 JPY
Share acquisition rights
750,000 JPY
750,000 JPY
Net assets
315,508,000 JPY
1,232,656,000 JPY
Liabilities and net assets
425,820,000 JPY
1,474,155,000 JPY
Liabilities
Current liabilities
Income taxes payable
25,017,000 JPY
31,131,000 JPY
Other
1,801,000 JPY
3,296,000 JPY
Net assets
Shareholders' equity

Talk to a Data Expert

Have a question? We'll get back to you promptly.